MedTrace Logo

Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve

NCT05397106 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2026-02-27

No results posted yet for this study

Summary

Post-Market Clinical Follow-up Registry of Patients with CODMAN CERTAS Plus Programmable Valves.

Conditions

  • Hydrocephalus
  • Hydrocephalus in Children
  • NPH (Normal Pressure Hydrocephalus)
  • IIH - Idiopathic Intracranial Hypertension
  • Brain Tumor
  • Post-Traumatic Hydrocephalus
  • Hemorrhagic Stroke

Interventions

DEVICE

CODMAN CERTAS Plus Programmable Valve

Patients will undergo implantation of the CODMAN CERTAS Plus Programmable Valve according to the device label.

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    lead INDUSTRY

Principal Investigators

  • Sherese Fralin, MSN, FNP, PhD · Integra LifeSciences

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-24
Primary Completion
2029-01-24
Completion
2029-01-24

Countries

  • Belgium
  • Germany
  • Spain
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05397106 on ClinicalTrials.gov